161 related articles for article (PubMed ID: 38734416)
1. Genetic ancestry, proportion of African ancestry, and apolipoprotein L1 risk variants in kidney recipients.
Zhang Z; Sun Z; Heeger P; Menon MC
Am J Transplant; 2024 May; ():. PubMed ID: 38734416
[No Abstract] [Full Text] [Related]
2. APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.
Hung AM; Shah SC; Bick AG; Yu Z; Chen HC; Hunt CM; Wendt F; Wilson O; Greevy RA; Chung CP; Suzuki A; Ho YL; Akwo E; Polimanti R; Zhou J; Reaven P; Tsao PS; Gaziano JM; Huffman JE; Joseph J; Luoh SW; Iyengar S; Chang KM; Casas JP; Matheny ME; O'Donnell CJ; Cho K; Tao R; Susztak K; Robinson-Cohen C; Tuteja S; Siew ED;
JAMA Intern Med; 2022 Apr; 182(4):386-395. PubMed ID: 35089317
[TBL] [Abstract][Full Text] [Related]
3. Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.
Nadkarni GN; Fei K; Ramos MA; Hauser D; Bagiella E; Ellis SB; Sanderson S; Scott SA; Sabin T; Madden E; Cooper R; Pollak M; Calman N; Bottinger EP; Horowitz CR
JAMA Netw Open; 2022 Mar; 5(3):e221048. PubMed ID: 35244702
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein L1 and Kidney Disease in African Americans.
Friedman DJ; Pollak MR
Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein L1 (APOL1) Coding Variants Are Associated With Creatinine Rise After Cardiac Surgery.
Privratsky JR; Li YJ; Haynes C; Podgoreanu M; Mathew J; Shah SH; Stafford-Smith M
J Cardiothorac Vasc Anesth; 2020 Dec; 34(12):3314-3320. PubMed ID: 32434723
[TBL] [Abstract][Full Text] [Related]
6. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
[TBL] [Abstract][Full Text] [Related]
7. African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.
Gordon EJ; Amόrtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
Am J Kidney Dis; 2018 Dec; 72(6):819-833. PubMed ID: 30360961
[TBL] [Abstract][Full Text] [Related]
8. A Focus Group Study on African American Living Donors' Treatment Preferences, Sociocultural Factors, and Health Beliefs About Apolipoprotein L1 Genetic Testing.
Gordon EJ; Amórtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
Prog Transplant; 2019 Sep; 29(3):239-247. PubMed ID: 31146624
[TBL] [Abstract][Full Text] [Related]
9. Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.
Ross LF; Thistlethwaite JR
Prog Transplant; 2016 Sep; 26(3):203-6. PubMed ID: 27302054
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients.
Harris DD; Fleishman A; Pavlakis M; Pollak MR; Baliga PK; Rohan V; Kayler LK; Rodrigue JR
J Surg Res; 2022 Sep; 277():116-124. PubMed ID: 35489216
[TBL] [Abstract][Full Text] [Related]
11. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
12. Stakeholder Perspectives on Returning Nonactionable Apolipoprotein L1 (APOL1) Genetic Results to African American Research Participants.
West KM; Cavanaugh KL; Blacksher E; Fullerton SM; Umeukeje EM; Young B; Burke W
J Empir Res Hum Res Ethics; 2022; 17(1-2):4-14. PubMed ID: 34870514
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein L1 and mechanisms of kidney disease susceptibility.
Bruggeman LA; Sedor JR; O'Toole JF
Curr Opin Nephrol Hypertens; 2021 May; 30(3):317-323. PubMed ID: 33767059
[TBL] [Abstract][Full Text] [Related]
14. APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
McLean NO; Robinson TW; Freedman BI
Am J Kidney Dis; 2017 Aug; 70(2):281-289. PubMed ID: 28143671
[TBL] [Abstract][Full Text] [Related]
15. Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.
Neugut YD; Mohan S; Gharavi AG; Kiryluk K
Ann Intern Med; 2019 Nov; 171(9):659-664. PubMed ID: 31590185
[TBL] [Abstract][Full Text] [Related]
16. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
[TBL] [Abstract][Full Text] [Related]
17. African ancestry-derived APOL1 risk genotypes show proximal epigenetic associations.
Breeze CE; Lin BM; Winkler CA; Franceschini N
BMC Genomics; 2024 May; 25(1):452. PubMed ID: 38714935
[TBL] [Abstract][Full Text] [Related]
18. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
19. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a culturally competent
Smith JD; Agrawal A; Wicklund C; Duquette D; Friedewald J; Rasmussen LV; Gacki-Smith J; Tandon SD; Muhammad LN; Yancy CW; Dong S; Cooper M; Gilbert A; Shetty A; Gordon EJ
BMJ Open; 2023 May; 13(5):e067657. PubMed ID: 37188469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
